The human side of hypoxia‐inducible factor

Abstract

Summary When humans are exposed to hypoxia, systemic and intracellular changes operate together to minimise hypoxic injury and restore adequate oxygenation. Emerging evidence indicates that the hypoxia‐inducible factor (HIF) family of transcription factors plays a central regulatory role in these homeostatic changes at both the systemic and cellular levels. HIF was discovered through its action as the transcriptional activator of erythropoietin, and has subsequently been found to control intracellular hypoxic responses throughout the body. HIF is primarily regulated by specific prolyl hydroxylase‐domain enzymes (PHDs) that initiate its degradation via the von Hippel‐Lindau tumour suppressor protein (VHL). The oxygen and iron dependency of PHD activity accounts for regulation of the pathway by both cellular oxygen and iron status. Recent studies conducted in patients with rare genetic diseases have begun to uncover the wider importance of the PHD‐VHL‐HIF axis in systems‐level human biology. These studies indicate that, in addition to regulating erythropoiesis, the system plays an important role in cardiopulmonary regulation. This article reviews our current understanding of the importance of HIF in human systems‐level physiology, and is modelled around the classic physiological response to high‐altitude hypoxia.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 101

1. 1.

   Aaronson PI, Robertson TP, Knock GA, Becker S, Lewis TH, Snetkov V, Ward JP. Hypoxic pulmonary vasoconstriction: mechanisms and controversies. Journal of Physiology. 2006;570:53-58.

   Not in our library10.1113/jphysiol.2005.098855

2. 2.

   Abbrecht PH, Littell JK. Plasma erythropoietin in men and mice during acclimatization to different altitudes. Journal of Applied Physiology. 1972;32:54-58.

   Not in our library10.1152/jappl.1972.32.1.54

3. 3.

   Al-Sheikh M, Moradkhani K, Lopez M, Wajcman H, Prehu C. Disturbance in the HIF-1α pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene. Blood Cells, Molecules and Diseases. 2007.

   Not in our library10.1016/j.bcmd.2007.07.017

4. 4.

   Ang S, Chen H, Hirota K, Gordeuk V, Jelinek J, Guan Y, Liu E, Sergueeva A, Miasnikova G, Mole D, Maxwell P, Stockton D, Semenza G, Prchal J. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nature Genetics. 2002;32:614-621.

   Not in our library10.1038/ng1019

5. 5.

   Balanos GM, Dorrington KL, Robbins PA. Desferrioxamine elevates pulmonary vascular resistance in humans: potential for involvement of HIF-1. Journal of Applied Physiology. 2002;92:2501-2507.

   Not in our library10.1152/japplphysiol.00965.2001

6. 6.

   Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. European Respiratory Journal. 2003;21:892-905.

   Not in our library10.1183/09031936.03.00115402

7. 7.

   Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO Journal. 2003;22:4082-4090.

   Not in our library10.1093/emboj/cdg392

8. 8.

   Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, Collen D, Carmeliet P. Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. Journal of Clinical Investigation. 2003;111:1519-1527.

   Not in our library10.1172/jci15496

9. 9.

   Bushuev VI, Miasnikova GY, Sergueeva AI, Polyakova LA, Okhotin D, Gaskin PR, Debebe Z, Nekhai S, Castro OL, Prchal JT, Gordeuk VR. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica. 2006;91:744-749.

   Not in our library

10. 10.

    Chen KF, Lai YY, Sun HS, Tsai SJ. Transcriptional repression of human cad gene by hypoxia inducible factor-1α. Nucleic Acids Research. 2005;33:5190-5198.

    Not in our library10.1093/nar/gki839

11. 11.

    Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. Journal of Biological Chemistry. 2000;275:25733-25741.

    Not in our library10.1074/jbc.m002740200

12. 12.

    Dorrington KL, Talbot NP. Human pulmonary vascular responses to hypoxia and hypercapnia. Pflügers Archive. 2004;449:1-15.

    Not in our library10.1007/s00424-004-1296-z

13. 13.

    Dorrington KL, Clar C, Young JD, Jonas M, Tansley JG, Robbins PA. Time-course of the human pulmonary vascular response to 8 hours of isocapnic hypoxia. American Journal of Physiology. 1997;273:H1126-H1134.

    Not in our library10.1152/ajpheart.1997.273.3.h1126

14. 14.

    Douglas CG, Haldane JS, Henderson Y, Schneider EC. Physiological observations made on Pike's Peak, Colorado, with special reference to adaptation to low barometric pressure. Philosophical Transactions of the Royal Society B. 1913;203:185-318.

    Not in our library

15. 15.

    Eckardt KU, Boutellier U, Kurtz A, Schopen M, Koller EA, Bauer C. Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. Journal of Applied Physiology. 1989;66:1785-1788.

    Not in our library10.1152/jappl.1989.66.4.1785

16. 16.

    Epstein A, Gleadle J, McNeill L, Hewitson K, O’Rourke J, Mole D, Mukherji M, Metzen E, Wilson M, Dhanda A, Tian Y, Masson N, Hamilton D, Jaakkola P, Barstead R, Hodgkin J, Maxwell P, Pugh C, Schofield C, Ratcliffe P. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43-54.

    Not in our library10.1016/s0092-8674(01)00507-4

17. 17.

    Erslev A. Humoral regulation of red cell production. Blood. 1953;8:349-357.

    Not in our library

18. 18.

    Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proceedings of the National Academy of Sciences U S A. 1994;91:6496-6500.

    Not in our library10.1073/pnas.91.14.6496

19. 19.

    Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology – American Society of Hematology Education Program. 2006;29-35.

    Not in our library10.1182/asheducation-2006.1.29

20. 20.

    Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. New England Journal of Medicine. 1993;328:1732-1739.

    Not in our library10.1056/nejm199306173282402

21. 21.

    Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, Butman JA, Jedlickova K, Prchal JT, Polyakova LA. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood. 2004;103:3924-3932.

    Not in our library10.1182/blood-2003-07-2535

22. 22.

    Gordeuk VR, Stockton DW, Prchal JT. Congenital polycythemias/erythrocytoses. Haematologica. 2005;90:109-116.

    Not in our library

23. 23.

    Grollman A. Physiological variariations of the cardiac output of man. VII. The effect of high altitude and its related functions: an account of experiments conducted on the summit of Pikes Peaks, Colorado. American Journal of Physiology. 1930;93:19-40.

    Not in our library

24. 24.

    Groves BM, Droma T, Sutton JR, McCullough RG, McCullough RE, Zhuang J, Rapmund G, Sun S, James C, Moore LG. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. Journal of Applied Physiology. 1993;74:312-318.

    Not in our library10.1152/jappl.1993.74.1.312

25. 25.

    Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α. Gene Expression. 1998;7:205-213.

    Not in our library

26. 26.

    Hackett PH, Roach RC. High-altitude illness. New England Journal of Medicine. 2001;345:107-114.

    Not in our library10.1056/nejm200107123450206

27. 27.

    Hewitson KS, Schofield CJ. The HIF pathway as a therapeutic target. Drug Discovery Today. 2004;9:704-711.

    Not in our library10.1016/s1359-6446(04)03202-7

28. 28.

    Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, Ratcliffe PJ, Pugh CW, Schofield CJ. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. Journal of Biological Chemistry. 2002;277:26351-26355.

    Not in our library10.1074/jbc.c200273200

29. 29.

    Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Critical Reviews in Oncology/Hematology. 2006;59:15-26.

    Not in our library10.1016/j.critrevonc.2005.12.003

30. 30.

    Hirshman CA, McCullough RE, Weil JV. Normal values for hypoxic and hypercapnic ventilatory drives in man. Journal of Applied Physiology. 1975;38:1095-1098.

    Not in our library10.1152/jappl.1975.38.6.1095

31. 31.

    Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. Journal of Biological Chemistry. 2003;278:30772-30780.

    Not in our library10.1074/jbc.m304982200

32. 32.

    Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. Journal of Biological Chemistry. 1996;271:32253-32259.

    Not in our library10.1074/jbc.271.50.32253

33. 33.

    Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences U S A. 1998;95:7987-7992.

    Not in our library10.1073/pnas.95.14.7987

34. 34.

    Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464-468.

    Not in our library10.1126/science.1059817

35. 35.

    Jaakkola P, Mole DR, Tian Y-M, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim AV, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468-472.

    Not in our library10.1126/science.1059796

36. 36.

    Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. Journal of Biological Chemistry. 1996;271:17771-17778.

    Not in our library10.1074/jbc.271.30.17771

37. 37.

    Kline DD, Peng Y-J, Manalo DJ, Semenza GL, Prabhakar NR. Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. Proceedings of the National Academy of Sciences U S A. 2002;99:821-826.

    Not in our library10.1073/pnas.022634199

38. 38.

    Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Research. 2003;63:1764-1768.

    Not in our library

39. 39.

    Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science. 2002;295:858-861.

    Not in our library10.1126/science.1068592

40. 40.

    Liu KX, Sun XC, Wang SW, Hu B. Association of polymorphisms of 1772 (C-<T) and 1790 (G-<A) in HIF1A gene with hypoxia adaptation in high altitude in Sherpas. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007;24:230-232.

    Not in our library

Cited by papers we hold 2

• ANDDigest: a new web-based module of ANDSystem for the search of knowledge in the scientific literature · 2020
  Not checked
• The Many Facets of Erythropoietin Physiologic and Metabolic Response · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.